These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 21795985)

  • 1. Outcome and risk factors for recurrence in malignant ovarian germ cell tumors: a MITO-9 retrospective study.
    Mangili G; Sigismondi C; Gadducci A; Cormio G; Scollo P; Tateo S; Ferrandina G; Greggi S; Candiani M; Lorusso D
    Int J Gynecol Cancer; 2011 Nov; 21(8):1414-21. PubMed ID: 21795985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of staging and adjuvant chemotherapy in stage I malignant ovarian germ cell tumors (MOGTs): the MITO-9 study.
    Mangili G; Sigismondi C; Lorusso D; Cormio G; Candiani M; Scarfone G; Mascilini F; Gadducci A; Mosconi AM; Scollo P; Cassani C; Pignata S; Ferrandina G
    Ann Oncol; 2017 Feb; 28(2):333-338. PubMed ID: 27803008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes and prognostic factors of patients with recurrent and persistent malignant ovarian germ cell tumors.
    Wang J; Zhuo X; Yang J; Cao D; Shen K; Huang H; Wu M; Pan L; Xiang Y; Guo L
    Arch Gynecol Obstet; 2020 Apr; 301(4):1021-1026. PubMed ID: 32198624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.
    Ghaemmaghami F; Hasanzadeh M; Karimi Zarchi M; Fallahi A
    Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of lymphadenectomy on prognosis and survival of clinically apparent early-stage malignant ovarian germ cell tumors.
    Qin B; Xu W; Li Y
    Jpn J Clin Oncol; 2020 Mar; 50(3):282-287. PubMed ID: 31867612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laparoscopic management of early-stage malignant nonepithelial ovarian tumors: surgical and survival outcomes.
    Shim SH; Kim DY; Lee SW; Park JY; Kim JH; Kim YM; Kim YT; Nam JH
    Int J Gynecol Cancer; 2013 Feb; 23(2):249-55. PubMed ID: 23318909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant ovarian germ cell tumors: a single-institution experience.
    Cicin I; Eralp Y; Saip P; Ayan I; Kebudi R; Iyibozkurt C; Tuzlali S; Gorgun O; Topuz E
    Am J Clin Oncol; 2009 Apr; 32(2):191-6. PubMed ID: 19307952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and pathologic features of patients with rare ovarian tumors: multi-center review of 167 patients by the anatolian society of medical oncology.
    Bilici A; Inanc M; Ulas A; Akman T; Seker M; Babacan NA; Inal A; Bal O; Koral L; Sevinc A; Tufan G; Elkiran ET; Ustaalioglu BB; Yavuzsen T; Alkis N; Ozkan M; Gumus M
    Asian Pac J Cancer Prev; 2014 Jan; 14(11):6493-9. PubMed ID: 24377556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic characteristics of malignant germ cell tumors in the ovaries of Korean women: a Korean Gynecologic Oncology Group Study.
    Lee KH; Lee IH; Kim BG; Nam JH; Kim WK; Kang SB; Ryu SY; Cho CH; Choi HS; Kim KT;
    Int J Gynecol Cancer; 2009 Jan; 19(1):84-7. PubMed ID: 19258947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of outcomes and prognostic factors after fertility-sparing surgery in malignant ovarian germ cell tumors.
    Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    Gynecol Oncol; 2017 Jun; 145(3):513-518. PubMed ID: 28372870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Analysis of Prognostic Factors in Patients with Ovarian Malignant Germ Cell Tumors Who Are Treated with Fertility-Preserving Surgery.
    Yang ZJ; Liu ZC; Wei RJ; Li L
    Gynecol Obstet Invest; 2016; 81(1):1-9. PubMed ID: 25967958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surveillance alone in stage I malignant ovarian germ cell tumors: a MITO (Multicenter Italian Trials in Ovarian cancer) prospective observational study.
    Mangili G; Giorda G; Ferrandina G; Cormio G; Cassani C; Savarese A; Danese S; Carnelli M; Vasta FM; Perrone AM; Scarfone G; Pignata S; Legge F; Raspagliesi F; Taccagni G; Candiani M; Bogani G; Mascilini F; Bergamini A
    Int J Gynecol Cancer; 2021 Sep; 31(9):1242-1247. PubMed ID: 34035080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of malignant ovarian germ cell tumors and preservation of fertility.
    Zhang R; Sun YC; Zhang GY; Wu LY; Zuo J
    Eur J Gynaecol Oncol; 2012; 33(5):489-92. PubMed ID: 23185794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is Omentectomy Mandatory Among Early Stage (I, II) Malignant Ovarian Germ Cell Tumor Patients? A Retrospective Study of 223 Cases.
    Xu W; Li Y
    Int J Gynecol Cancer; 2017 Sep; 27(7):1373-1378. PubMed ID: 28520571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome and prognostic factors in ovarian germ cell malignancies.
    Lai CH; Chang TC; Hsueh S; Wu TI; Chao A; Chou HH; Wang PN
    Gynecol Oncol; 2005 Mar; 96(3):784-91. PubMed ID: 15721426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant germ cell tumors of the ovary: a review of 41 cases and risk factors for recurrence.
    Topuz S; Iyibozkurt AC; Akhan SE; Keskin N; Yavuz E; Salihoglu Y; Bengisu E; Berkman S
    Eur J Gynaecol Oncol; 2008; 29(6):635-7. PubMed ID: 19115694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors. A review of 74 cases.
    Low JJ; Perrin LC; Crandon AJ; Hacker NF
    Cancer; 2000 Jul; 89(2):391-8. PubMed ID: 10918171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fertility-Sparing Surgery Should Be the Standard Treatment in Patients with Malignant Ovarian Germ Cell Tumors.
    Turkmen O; Karalok A; Basaran D; Kimyon GC; Tasci T; Ureyen I; Tulunay G; Turan T
    J Adolesc Young Adult Oncol; 2017 Jun; 6(2):270-276. PubMed ID: 28085535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical management of malignant ovarian germ cell tumors: A 26-year experience in a tertiary care institution.
    Hu T; Fang Y; Sun Q; Zhao H; Ma D; Zhu T; Wang C
    Surg Oncol; 2019 Dec; 31():8-13. PubMed ID: 31446304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of bilateral malignant ovarian germ cell tumors: a MITO-9 retrospective study.
    Sigismondi C; Scollo P; Ferrandina G; Candiani M; Angioli R; Viganò R; Scarfone G; Mangili G
    Int J Gynecol Cancer; 2015 Feb; 25(2):203-7. PubMed ID: 25569816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.